Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016

Filetype[PDF-504.25 KB]


  • English
    • Details Supporting Files Related Documents You May Also Like

    Details:

    • Alternative Title:
      MMWR Morb Mortal Wkly Rep
    • Personal Author:
    • Description:
      Introduction

      Despite decades-long reductions in cardiovascular disease (CVD) Mortality, CVD Mortality rates have recently plateaued and even increased in some subgroups, and the prevalence of CVD risk factors remains high. Million Hearts 2022, a 5-year initiative, was launched in 2017 to address this burden. This report establishes a baseline for the CVD risk factors targeted for reduction by the initiative during 2017–2021 and highlights recent changes over time.

      Methods

      Risk factor prevalence among U.S. adults was assessed using data from the National Health and Nutrition Examination Survey (U.S.), National Survey on Drug Use and Health, and National Health Interview Survey. Multivariate analyses were performed to assess differences in prevalence during 2011–2012 and the most recent cycle of available data, and across subgroups.

      Results

      During 2013–2014, the prevalences of aspirin use for primary and secondary CVD Prevention were 27.4% and 74.9%, respectively, and of statin use for cholesterol management was 54.5%. During 2015–2016, the average daily sodium intake was 3,535 mg/day and the prevalences of blood pressure control, combustible tobacco use, and physical inactivity were 48.5%, 22.3%, and 29.1%, respectively. Compared with 2011–2012, significant decreases occurred in the prevalences of combustible tobacco use and physical inactivity; however, a decrease also occurred for aspirin use for primary or secondary Prevention. Disparities in risk factor prevalences were observed across age groups, genders, and racial/ethnic groups.

      Conclusions and Implications for Public Health Practice

      Millions of Americans have CVD risk factors that place them at increased risk for having a cardiovascular event, despite the existence of proven strategies for preventing or managing CVD risk factors. A concerted effort to implement these strategies will be needed to prevent one million acute cardiovascular events during the 5-year initiative.

    • Subjects:
    • Source:
      MMWR Morb Mortal Wkly Rep. 67(35):983-991.
    • Pubmed ID:
      30188885
    • Pubmed Central ID:
      PMC6132182
    • Document Type:
      Journal Article
    • Place as Subject:
      United States
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov